A Louisiana Pradaxa lawyer notes that members of the medical community are hopeful that a new reversal agent for the blood-thinning drug Pradaxa will allow medical professionals to focus more on patient care and less on concerns about the drug’s potential to cause brain bleeding. The reversal agent was approved by the U.S. Food and Drug Administration (FDA) to counteract brain bleeding in patients who are taking Pradaxa to reduce their risk of stroke. Patients who have suffered complications after taking Pradaxa may be eligible to seek compensation with the assistance of Louisiana Pradaxa attorneys.
For more information, contact Attorney Group for Louisiana. We offer free, confidential, no obligation consultations. We can help answer your questions, and if you choose to pursue a case we can connect you with an affiliated Pradaxa lawsuit attorney who can assist you throughout the legal process.
Report: Pradaxa Manufacturer Has Already Paid Out $650 Million in Settlements
A new drug called Praxbind (idarucizumab) has been shown to reverse the blood-thinning effects of Pradaxa (dabigatran) in patients with brain bleeding, according to research presented at the 2016 International Stroke Conference of the American Stroke Association. According to Tech Times, Praxbind, was approved by the FDA in 2015. The reversal drug is used to counteract brain bleeding in patients who are taking Pradaxa after being diagnosed with atrial fibrillation.
While Pradaxa does reduce the chances of blood clots forming in the heart in patients with atrial fibrillation, it isn’t without its own risks. Complications and disabilities have been reported among some patients who have taken Pradaxa and some patients have experienced a type of brain bleed known as an intracranial hemorrhage. To date, Praxbind is the only agent approved by the FDA to reverse the effects of Pradaxa.
Pradaxa has been linked to hundreds of deaths and thousands of patients have reported suffering severe side effects after taking the drug. In 2014, drug maker, Boehringer Ingelheim, announced that it would pay $650 million to settle 4,000 state and federal Pradaxa lawsuits. The lawsuits claimed that Pradaxa caused bleeding events that could not be controlled. In 2011 alone, more than 540 patients lost their lives after using Pradaxa, according to FDA reports.
How a Louisiana Pradaxa Lawyer Can Help
Drug makers have a duty to provide safe products. If there are risks of harm associated with their products, they also must provide adequate warnings. If a drug maker fails to fulfill this duty, it could be held liable in lawsuits for injuries that may result.
People injured by bad drugs may be eligible to recover money for:
- Medical Expenses
- Lost Wages
- Pain and Suffering
The families of those who have died may be eligible to recover money for funeral expenses and the pain that comes with losing a loved one.
The Time You Have to Pursue a Claim is Limited. Contact Us Today.
For more information, contact Attorney Group for Louisiana. You can fill out the form on this page or contact us by phone or email.
After you contact us, an attorney will follow up to answer questions that you might have. There is no cost or obligation to speak with us, and any information you provide will be kept confidential.
Please note that the law limits the time you have to pursue a claim or file a lawsuit for an injury. If you think you have a case, you should not delay taking action.
